172 related articles for article (PubMed ID: 23554532)
1. Managing tuberculosis in people who use and inject illicit drugs.
Getahun H; Baddeley A; Raviglione M
Bull World Health Organ; 2013 Feb; 91(2):154-6. PubMed ID: 23554532
[No Abstract] [Full Text] [Related]
2. The perfect storm: incarceration and the high-risk environment perpetuating transmission of HIV, hepatitis C virus, and tuberculosis in Eastern Europe and Central Asia.
Altice FL; Azbel L; Stone J; Brooks-Pollock E; Smyrnov P; Dvoriak S; Taxman FS; El-Bassel N; Martin NK; Booth R; Stöver H; Dolan K; Vickerman P
Lancet; 2016 Sep; 388(10050):1228-48. PubMed ID: 27427455
[TBL] [Abstract][Full Text] [Related]
3. Who: four ways to reduce hepatitis infections in people who inject drugs.
Cent Eur J Public Health; 2012 Sep; 20(3):207. PubMed ID: 23285521
[No Abstract] [Full Text] [Related]
4. Tuberculosis and HIV in people who inject drugs: evidence for action for tuberculosis, HIV, prison and harm reduction services.
Getahun H; Gunneberg C; Sculier D; Verster A; Raviglione M
Curr Opin HIV AIDS; 2012 Jul; 7(4):345-53. PubMed ID: 22678489
[TBL] [Abstract][Full Text] [Related]
5. Global burden of HIV, viral hepatitis, and tuberculosis in prisoners and detainees.
Dolan K; Wirtz AL; Moazen B; Ndeffo-Mbah M; Galvani A; Kinner SA; Courtney R; McKee M; Amon JJ; Maher L; Hellard M; Beyrer C; Altice FL
Lancet; 2016 Sep; 388(10049):1089-1102. PubMed ID: 27427453
[TBL] [Abstract][Full Text] [Related]
6. Risk factors for HBV/HIV/HCV in drug addicts: a survey of attendees of a department of pathological dependence.
Napoli C; Tafuri S; Pignataro N; Tedesco G; Maria AS; Quarto M
J Prev Med Hyg; 2010 Sep; 51(3):101-4. PubMed ID: 21361113
[TBL] [Abstract][Full Text] [Related]
7. The road to HIV and HCV elimination among people who inject drugs.
Corona-Mata D; Rivero-Juarez A
Lancet Gastroenterol Hepatol; 2023 Jun; 8(6):497-498. PubMed ID: 36996851
[No Abstract] [Full Text] [Related]
8. Inmates in Irish prisons face drug abuse and disease.
Birchard K
Lancet; 1999 Aug; 354(9180):753. PubMed ID: 10475200
[No Abstract] [Full Text] [Related]
9. Hepatitis C virus infection and substance abuse: medical management and developing models of integrated care--an introduction.
Kresina TF; Khalsa J; Cesari H; Francis H
Clin Infect Dis; 2005 Apr; 40 Suppl 5():S259-62. PubMed ID: 15768332
[No Abstract] [Full Text] [Related]
10. Developing integrated community-based HIV prevention, harm reduction, and sexual and reproductive health services for women who inject drugs.
Ayon S; Jeneby F; Hamid F; Badhrus A; Abdulrahman T; Mburu G
Reprod Health; 2019 May; 16(Suppl 1):59. PubMed ID: 31138238
[TBL] [Abstract][Full Text] [Related]
11. HIV revisited: preventing the spread of blood-borne viruses among injecting drug users.
Wodak A; Crofts N
Aust J Public Health; 1994 Sep; 18(3):239-41. PubMed ID: 7841248
[No Abstract] [Full Text] [Related]
12. Human immunodeficiency virus, hepatitis B and hepatitis C in an Indonesian prison: prevalence, risk factors and implications of HIV screening.
Nelwan EJ; Van Crevel R; Alisjahbana B; Indrati AK; Dwiyana RF; Nuralam N; Pohan HT; Jaya I; Meheus A; Van Der Ven A
Trop Med Int Health; 2010 Dec; 15(12):1491-8. PubMed ID: 20955370
[TBL] [Abstract][Full Text] [Related]
13. [Prevalence of HIV and hepatitis B and C among drug addicts in the city of Copenhagen].
Fuglsang T; Fouchard JR; Ege PP
Ugeskr Laeger; 2000 Jul; 162(27):3860-4. PubMed ID: 10920701
[TBL] [Abstract][Full Text] [Related]
14. Ongoing HIV and viral hepatitis infections in IDUs across the EU, 2001-2005.
Wiessing L; Nardone A
Euro Surveill; 2006 Nov; 11(11):E061123.2. PubMed ID: 17213556
[No Abstract] [Full Text] [Related]
15. Prevalence of HIV, hepatitis B and hepatitis C and associated risk behaviours amongst injecting drug users in three Afghan cities.
Nasir A; Todd CS; Stanekzai MR; Bautista CT; Botros BA; Scott PT; Strathdee SA; Tjaden J
Int J Drug Policy; 2011 Mar; 22(2):145-52. PubMed ID: 21146392
[TBL] [Abstract][Full Text] [Related]
16. Hepatitis B, hepatitis C, and HIV in correctional populations: a review of epidemiology and prevention.
Weinbaum CM; Sabin KM; Santibanez SS
AIDS; 2005 Oct; 19 Suppl 3():S41-6. PubMed ID: 16251827
[TBL] [Abstract][Full Text] [Related]
17. [Control of the diffusion of viral hepatitis in detention and penal institutions: a problem not to be underrated].
Patti AM; Pompa MG; Santi AL
Ann Ig; 1992; 4(2):73-6. PubMed ID: 1283946
[No Abstract] [Full Text] [Related]
18. Prisons, prisoners, and hepatitis C.
Ferguson L; Batey R
J Gastroenterol Hepatol; 2010 Jul; 25(7):1184-6. PubMed ID: 20594243
[No Abstract] [Full Text] [Related]
19. Illicit drugs in Central Asia: what we know, what we don’t know, and what we need to know.
Latypov A; Grund JP; El-Bassel N; Platt L; Stöver H; Strathdee S
Int J Drug Policy; 2014 Nov; 25(6):1155-62. PubMed ID: 25449055
[No Abstract] [Full Text] [Related]
20. Prevalence and risk factors associated with HIV/hepatitis B and HIV/hepatitis C co-infections among people who inject drugs in Mozambique.
Semá Baltazar C; Boothe M; Kellogg T; Ricardo P; Sathane I; Fazito E; Raymond HF; Temmerman M; Luchters S
BMC Public Health; 2020 Jun; 20(1):851. PubMed ID: 32493347
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
